paclitaxel and pkh 26
paclitaxel has been researched along with pkh 26 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bapat, SA; Kusumbe, AP | 1 |
| Bernasconi, S; Bono, F; Broggini, M; Damia, G; Fruscio, R; Ganzinelli, M; Mangioni, C; Perego, P; Ricci, F; Russo, G; Signorelli, M | 1 |
Other Studies
2 other study(ies) available for paclitaxel and pkh 26
| Article | Year |
|---|---|
Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy.
Topics: Aneuploidy; Animals; Antineoplastic Agents, Phytogenic; Cell Growth Processes; Cell Line, Tumor; Cystadenocarcinoma, Serous; Female; Flow Cytometry; Fluorescent Dyes; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Organic Chemicals; Ovarian Neoplasms; Paclitaxel | 2009 |
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma; Cell Differentiation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Fluorescent Antibody Technique, Indirect; Humans; Mesenchymal Stem Cells; Neoplasm Proteins; Neoplastic Stem Cells; Organic Chemicals; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured | 2012 |